Logo image of ALMIB.PA

AMOEBA SAS (ALMIB.PA) Stock Fundamental Analysis

EPA:ALMIB - FR0011051598 - Common Stock

0.88 EUR
+0.01 (+1.15%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

0

ALMIB gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 68 industry peers in the Chemicals industry. Both the profitability and financial health of ALMIB have multiple concerns. ALMIB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ALMIB had negative earnings in the past year.
ALMIB had a negative operating cash flow in the past year.
In the past 5 years ALMIB always reported negative net income.
In the past 5 years ALMIB always reported negative operating cash flow.
ALMIB.PA Yearly Net Income VS EBIT VS OCF VS FCFALMIB.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M

1.2 Ratios

ALMIB has a Return On Assets of -116.64%. This is amonst the worse of the industry: ALMIB underperforms 95.59% of its industry peers.
Industry RankSector Rank
ROA -116.64%
ROE N/A
ROIC N/A
ROA(3y)-136.25%
ROA(5y)-104.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALMIB.PA Yearly ROA, ROE, ROICALMIB.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K -2K 4K

1.3 Margins

ALMIB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALMIB.PA Yearly Profit, Operating, Gross MarginsALMIB.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

0

2. Health

2.1 Basic Checks

The number of shares outstanding for ALMIB has been increased compared to 1 year ago.
The number of shares outstanding for ALMIB has been increased compared to 5 years ago.
ALMIB has a worse debt/assets ratio than last year.
ALMIB.PA Yearly Shares OutstandingALMIB.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ALMIB.PA Yearly Total Debt VS Total AssetsALMIB.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of -7.78, we must say that ALMIB is in the distress zone and has some risk of bankruptcy.
ALMIB has a worse Altman-Z score (-7.78) than 91.18% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.78
ROIC/WACCN/A
WACCN/A
ALMIB.PA Yearly LT Debt VS Equity VS FCFALMIB.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M

2.3 Liquidity

ALMIB has a Current Ratio of 0.42. This is a bad value and indicates that ALMIB is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.42, ALMIB is not doing good in the industry: 95.59% of the companies in the same industry are doing better.
A Quick Ratio of 0.37 indicates that ALMIB may have some problems paying its short term obligations.
ALMIB has a worse Quick ratio (0.37) than 94.12% of its industry peers.
Industry RankSector Rank
Current Ratio 0.42
Quick Ratio 0.37
ALMIB.PA Yearly Current Assets VS Current LiabilitesALMIB.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

ALMIB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.20%, which is quite impressive.
EPS 1Y (TTM)54.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.72%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, ALMIB will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.60% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y3.94%
EPS Next 2Y0.21%
EPS Next 3Y16.6%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALMIB.PA Yearly Revenue VS EstimatesALMIB.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2025 2026 2027 5M 10M
ALMIB.PA Yearly EPS VS EstimatesALMIB.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2022 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALMIB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ALMIB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALMIB.PA Price Earnings VS Forward Price EarningsALMIB.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALMIB.PA Per share dataALMIB.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.05 -0.1 -0.15

4.3 Compensation for Growth

A more expensive valuation may be justified as ALMIB's earnings are expected to grow with 16.60% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.21%
EPS Next 3Y16.6%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALMIB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMOEBA SAS

EPA:ALMIB (9/5/2025, 7:00:00 PM)

0.88

+0.01 (+1.15%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)03-26 2025-03-26
Earnings (Next)10-01 2025-10-01
Inst Owners0.24%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap60.65M
Analysts89.09
Price Target1.53 (73.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10.36%
PT rev (3m)-8.54%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)20.58%
EPS NY rev (3m)20.58%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.13
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0
BVpS-0.15
TBVpS-0.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -116.64%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-136.25%
ROA(5y)-104.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 267.6%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.42
Quick Ratio 0.37
Altman-Z -7.78
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)289.55%
Cap/Depr(5y)177.33%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.72%
EPS Next Y3.94%
EPS Next 2Y0.21%
EPS Next 3Y16.6%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y59.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2.68%
EBIT Next 3Y37.51%
EBIT Next 5YN/A
FCF growth 1Y50%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y35.18%
OCF growth 3YN/A
OCF growth 5YN/A